News

blog

Efficacy and safety of non-vitamin K antagonist oral anticoagulants compared with warfarin in patients with atrial fibrillation.

Non-vitamin K antagonist oral anticoagulants reduce all-cause mortality, major bleeding and intracerebral hemorrhage but higher risk of gastro-intestinal bleeding according to...
Read more

The compass study

Rivaroxaban significantly lowered the combined risk of stroke, cardiovascular death and heart attack in patient with chronic coronary or peripheral artery disease by 24% Im...
Read more